“Sutro’s open biochemical protein synthesis technology platform potentially resolves many of the problems inherent in other approaches, and we are looking forward to the mutual success of our collaboration.”

Jaume Pons, Ph.D.,
Vice President and Chief Scientific Officer at Pfizer's Rinat subsidiary